Phase 3 Cervical Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are willing to take part and able to sign a consent form agreeing to join the study.
- You are able to provide a tissue sample from a primary or secondary (spread) cancer.
- You have at least one tumor that can be measured on a scan.
- Your doctor expects you to live for more than 3 months.
- You are generally well enough to carry out daily activities with little or no limitation (confirm with trial site).
- Your organs (such as your liver, kidneys, and heart) are working well enough to take part.
Who may not be able to join:
- Your cancer has spread to lymph nodes or other areas in certain specific parts of the body, as confirmed by a scan or biopsy (confirm with trial site).
- You have received a live vaccine within the 4 weeks before joining, or plan to receive one during the study.
- You have taken medication that suppresses your immune system within the 4 weeks before joining.
- You are currently receiving blood-thinning (anticoagulant) treatment, unless it is a low-dose preventative dose only.
- You have had another cancer that has not been fully treated or cured within the past 5 years, unless it was a specific type of skin cancer or a very early-stage cancer that was fully cured.
- You have a known allergy to the study drug or its ingredients, or have had a severe allergic reaction to a similar type of drug (called a monoclonal antibody).
- You are currently pregnant or breastfeeding.
- You have any other health condition or circumstance that the study doctor believes could put you at risk or affect the study results.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86-0518-82342973
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Progression-free survival (PFS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.